Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13312-021-2308-1 http://scihub22266oqcxt.onion/10.1007/s13312-021-2308-1 34302326!8464187!34302326     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34302326&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Indian+Pediatr 2021 ; 58 (9): 853-856 Nephropedia Template TP {{tp|p=34302326|t=2021. Outcome of Neonates Born to COVID-Positive Women at 6 Months of Age |pdf=|usr=}}{{34302326}} gab.com Text Outcome of Neonates Born to COVID-Positive Women at 6 Months of Age JO: Indian Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=34302326 #FOAvip OBJECTIVES: To compare clinical and neurodevelopmental outcome at the age of 6 months for neonates born to SARS-CoV-2-positive mothers. METHODS: Neonates of SARS-CoV-2 positive mothers, admitted in our hospital were assessed for growth, neurodevelopment by Amiel-Tison method, and Developmental Profile (DP3) at discharge as part of another study (July 2020). This data were retrieved and babies followed-up at the age of 6 months. Composite adverse outcome was death within 6 months post discharge or DP3 score <70 and hearing/visual deficit. RESULTS: Out of 131 enrolled at discharge, 127 (97%) were followed up. SARs-CoV-2 positive neonates (Group I; 19, 15%) had more symptoms (P=0.012), sepsis (P=0.014), pneumonia (P=0.029), longer hospital stay (P<0.001) following birth compared to group II (SARs-CoV-2 negative neonates;108, 85%). No baby in group I met definition of composite adverse outcome, while in group II it was 0.9% (1 child with DP3 <70 with hearing deficit) (P=1.0) without any difference in hospital readmission, growth, DP3 scores, or tone abnormalities. CONCLUSIONS: There is no difference in growth, neurodevelopment, and hospital readmission in early infancy among infected and non-infected babies born to SARS-CoV-2 positive mothers. Twit Text FOAVip Outcome of Neonates Born to COVID-Positive Women at 6 Months of Age ????Indian Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=34302326 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34302326 #FOAvip English Wikipedia <ref>{{Cite pmid|34302326}}</ref> Outcome of Neonates Born to COVID-Positive Women at 6 Months of Age #MMPMID34302326 Munian D; Das R; Hazra A; Ray S Indian Pediatr 2021[Sep]; 58 (9): 853-856 PMID34302326show ga OBJECTIVES: To compare clinical and neurodevelopmental outcome at the age of 6 months for neonates born to SARS-CoV-2-positive mothers. METHODS: Neonates of SARS-CoV-2 positive mothers, admitted in our hospital were assessed for growth, neurodevelopment by Amiel-Tison method, and Developmental Profile (DP3) at discharge as part of another study (July 2020). This data were retrieved and babies followed-up at the age of 6 months. Composite adverse outcome was death within 6 months post discharge or DP3 score <70 and hearing/visual deficit. RESULTS: Out of 131 enrolled at discharge, 127 (97%) were followed up. SARs-CoV-2 positive neonates (Group I; 19, 15%) had more symptoms (P=0.012), sepsis (P=0.014), pneumonia (P=0.029), longer hospital stay (P<0.001) following birth compared to group II (SARs-CoV-2 negative neonates;108, 85%). No baby in group I met definition of composite adverse outcome, while in group II it was 0.9% (1 child with DP3 <70 with hearing deficit) (P=1.0) without any difference in hospital readmission, growth, DP3 scores, or tone abnormalities. CONCLUSIONS: There is no difference in growth, neurodevelopment, and hospital readmission in early infancy among infected and non-infected babies born to SARS-CoV-2 positive mothers. |*COVID-19[MESH] |*Pregnancy Complications, Infectious[MESH] |Aftercare[MESH] |Child[MESH] |Female[MESH] |Humans[MESH] |Infant[MESH] |Infant, Newborn[MESH] |Infectious Disease Transmission, Vertical[MESH] |Patient Discharge[MESH] |Pregnancy[MESH] |Pregnancy Outcome[MESH]Outcome of Neonates Born to COVID-Positive Women at 6 Months of Age (epmc).pdf DeepDyve Pubget Overpricing